| Literature DB >> 131731 |
R O Chiprut, A Viteri, C Jamroz, W P Dyck.
Abstract
The occurrence of cholestatic jaundice in a patient receiving griseofulvin is described. The clinical manifestations, laboratory features, and pathological lesion of drug-induced hepatotoxicity are discussed. Complete recovery followed the discontinuation of drug administration. The potential hepatotoxicity of griseofulvin and the importance of close monitoring of liver function studies in patients receiving this drug are emphasized.Entities:
Mesh：
Substances：
Year: 1976 PMID： 131731
Source DB: PubMed Journal: Gastroenterology ISSN： 0016-5085 Impact factor: 22.682